“…The pharmacologic agents latrunculin and cytochalasin, which inhibit actin polymerization by sequestering G-actin monomers and by capping actin filaments, respectively (17,32,35), have been widely employed in a variety of smooth muscle tissue and cell types to evaluate the effects of inhibiting actin polymerization on contractile responses to agonist stimulation. Studies of airway smooth muscle (6,43,84,115,131,140), vascular smooth muscle (1,25,27,28,92,93,104,107,112,138), and uterine (112) and intestinal smooth muscle (81,91) have all shown that the short-term exposure of smooth muscle tissues to inhibitors of actin polymerization causes a profound suppression of tension development and an inhibition of shortening or constriction. Additional evidence that actin polymerization plays a critical role in the process of mechanical tension development in smooth muscle comes from studies showing that molecular constructs or peptides that disrupt specific steps in the actin polymerization process also inhibit tension development in smooth muscle tissues in response to contractile stimuli (7,123,127,128,143,144).…”